CannBioRx Life Sciences Corp.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$19,935,112 over the previous period. Total operating expenses were $13,477,500.
Profit Margin
| 2017 | 0 | 123.76K | |
|---|---|---|---|
| 2018 | 0 | -14.49M | |
| 2019 | 0 | -25.39M | |
| 2020 | 0 | -12.00M | |
| 2021 | 0 | -20.32M | |
| 2022 | 0 | -38.72M | |
| 2023 | 0 | -19.93M |
ATNFW Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 105.67K | 109.00K | 116.29K | 125.33K | 72.24K | 0 | 0 |
Gross profit | -105.67K | -109.00K | -116.29K | -125.33K | -72.24K | 0 | 0 |
Operating exp. | |||||||
Research and development | 2.78M | 2.43M | 3.94M | 2.29M | 2.03M | 1.07M | 0 |
Selling and marketing | 0 | 0 | 0 | 38.83K | 12.95M | 0 | 0 |
Total operating expenses | 13.47M | 39.64M | 20.16M | 9.81M | 25.22M | 14.50M | 343.88K |
Operating income | -13.47M | -17.89M | -15.64M | -5.64M | -20.86M | -8.74M | -343.88K |
Other income (expenses), net | -8.80M | -21.77M | -4.70M | -5.25M | -4.54M | -5.75M | 663.01K |
Income before tax | -22.28M | -39.66M | -20.34M | -10.90M | -25.40M | -14.49M | 319.13K |
Income tax expense | -2.34M | 942.74K | 23.20K | 20.42K | 9.49K | -1 | 195.36K |
Net income | -19.93M | -38.72M | -20.32M | -12.00M | -25.39M | -14.49M | 123.76K |
Earnings per share | |||||||
Basic EPS | -52.6 | -387.26 | -247.86 | -255.46 | -875.66 | -1.44K | 12.38 |
Diluted EPS | -52.59 | -387.18 | -246.32 | -251.32 | -874.45 | -1.44K | 12.38 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |